These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 20964200)

  • 1. QA procedures for multimodality preclinical tumor drug response testing.
    Lee YC; Goins BA; Fullerton GD
    Med Phys; 2010 Sep; 37(9):4806-16. PubMed ID: 20964200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of a preclinical multimodality phantom using tissue-mimicking materials for quality assurance in tumor size measurement.
    Lee YC; Fullerton GD; Goins BA
    J Vis Exp; 2013 Jul; (77):. PubMed ID: 23928940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical multimodality phantom design for quality assurance of tumor size measurement.
    Lee YC; Fullerton GD; Baiu C; Lescrenier MG; Goins BA
    BMC Med Phys; 2011 Sep; 11():1. PubMed ID: 21958653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of a dynamic quality assurance testing protocol for multisite clinical trial DCE-CT accreditation.
    Driscoll B; Keller H; Jaffray D; Coolens C
    Med Phys; 2013 Aug; 40(8):081906. PubMed ID: 23927320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor response evaluation in oncology: current update.
    Shanbhogue AK; Karnad AB; Prasad SR
    J Comput Assist Tomogr; 2010 Jul; 34(4):479-84. PubMed ID: 20657213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A quality assurance framework for the fully automated and objective evaluation of image quality in cone-beam computed tomography.
    Steiding C; Kolditz D; Kalender WA
    Med Phys; 2014 Mar; 41(3):031901. PubMed ID: 24593719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Technical Note: Multipurpose CT, ultrasound, and MRI breast phantom for use in radiotherapy and minimally invasive interventions.
    Ruschin M; Davidson SR; Phounsy W; Yoo TS; Chin L; Pignol JP; Ravi A; McCann C
    Med Phys; 2016 May; 43(5):2508. PubMed ID: 27147361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a dynamic flow imaging phantom for dynamic contrast-enhanced CT.
    Driscoll B; Keller H; Coolens C
    Med Phys; 2011 Aug; 38(8):4866-80. PubMed ID: 21928658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative PET/CT scanner performance characterization based upon the society of nuclear medicine and molecular imaging clinical trials network oncology clinical simulator phantom.
    Sunderland JJ; Christian PE
    J Nucl Med; 2015 Jan; 56(1):145-52. PubMed ID: 25525180
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A statistical simulation study finds discordance between WHO criteria and RECIST guideline.
    Mazumdar M; Smith A; Schwartz LH
    J Clin Epidemiol; 2004 Apr; 57(4):358-65. PubMed ID: 15135836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical introduction of a linac head-mounted 2D detector array based quality assurance system in head and neck IMRT.
    Korevaar EW; Wauben DJ; van der Hulst PC; Langendijk JA; Van't Veld AA
    Radiother Oncol; 2011 Sep; 100(3):446-52. PubMed ID: 21963288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary tumor measurements from x-ray computed tomography in one, two, and three dimensions.
    Villemaire L; Owrangi AM; Etemad-Rezai R; Wilson L; O'Riordan E; Keller H; Driscoll B; Bauman G; Fenster A; Parraga G
    Acad Radiol; 2011 Nov; 18(11):1391-402. PubMed ID: 21917485
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discrepancy in the assessment of tumor response in patients with pancreatic cancer: WHO versus RECIST criteria.
    Ahn SH; Garewal HS; Dragovich T
    J BUON; 2008; 13(3):359-62. PubMed ID: 18979550
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma.
    Lencioni R; Llovet JM
    Semin Liver Dis; 2010 Feb; 30(1):52-60. PubMed ID: 20175033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of a fused phantom for quantitative evaluation of brain metabolites and enhanced quality assurance testing for magnetic resonance imaging and spectroscopy.
    Song KH; Kim SY; Lee DW; Jung JY; Lee JH; Baek HM; Choe BY
    J Neurosci Methods; 2015 Nov; 255():75-84. PubMed ID: 26277420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The feasibility study and characterization of a two-dimensional diode array in "magic phantom" for high dose rate brachytherapy quality assurance.
    Espinoza A; Beeksma B; Petasecca M; Fuduli I; Porumb C; Cutajar D; Corde S; Jackson M; Lerch ML; Rosenfeld AB
    Med Phys; 2013 Nov; 40(11):111702. PubMed ID: 24320410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a line-pair resolution phantom for comprehensive quality assurance of electronic portal imaging devices based on fundamental imaging metrics.
    Gopal A; Samant SS
    Med Phys; 2009 Jun; 36(6):2006-15. PubMed ID: 19610289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiologic measurements of tumor response to treatment: practical approaches and limitations.
    Suzuki C; Jacobsson H; Hatschek T; Torkzad MR; Bodén K; Eriksson-Alm Y; Berg E; Fujii H; Kubo A; Blomqvist L
    Radiographics; 2008; 28(2):329-44. PubMed ID: 18349443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technical Note: A new phantom design for routine testing of Doppler ultrasound.
    Grice JV; Pickens DR; Price RR
    Med Phys; 2016 Jul; 43(7):4431. PubMed ID: 27370158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RECIST 1.1 - Standardisation and disease-specific adaptations: Perspectives from the RECIST Working Group.
    Schwartz LH; Seymour L; Litière S; Ford R; Gwyther S; Mandrekar S; Shankar L; Bogaerts J; Chen A; Dancey J; Hayes W; Hodi FS; Hoekstra OS; Huang EP; Lin N; Liu Y; Therasse P; Wolchok JD; de Vries E
    Eur J Cancer; 2016 Jul; 62():138-45. PubMed ID: 27237360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.